These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33397196)

  • 1. Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing.
    Selvaraj N; Wang CK; Bowser B; Broadt T; Shaban S; Burns J; Saptharishi N; Pechan P; Golebiowski D; Alimardanov A; Yang N; Mitra G; Vepachedu R
    Hum Gene Ther; 2021 Aug; 32(15-16):850-861. PubMed ID: 33397196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.
    Ye GJ; Scotti MM; Thomas DL; Wang L; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):212-7. PubMed ID: 25357151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of striatum and cortex tissues by adeno-associated viral vectors produced by herpes simplex virus- and baculovirus-based methods.
    Zhang HS; Kim E; Lee S; Ahn IS; Jang JH
    J Virol Methods; 2012 Jan; 179(1):276-80. PubMed ID: 22015677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
    Thomas DL; Wang L; Niamke J; Liu J; Kang W; Scotti MM; Ye GJ; Veres G; Knop DR
    Hum Gene Ther; 2009 Aug; 20(8):861-70. PubMed ID: 19419276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A versatile adeno-associated virus vector producer cell line method for scalable vector production of different serotypes.
    Yuan Z; Qiao C; Hu P; Li J; Xiao X
    Hum Gene Ther; 2011 May; 22(5):613-24. PubMed ID: 21186998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line.
    Escandell J; Moura F; Carvalho SB; Silva RJS; Correia R; Roldão A; Gomes-Alves P; Alves PM
    Biotechnol Bioeng; 2023 Sep; 120(9):2578-2587. PubMed ID: 37027346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the design space of AAV transient-transfection in suspension cell lines.
    Meade O; Clark J; McCutchen M; Kerwin J
    Methods Enzymol; 2021; 660():341-360. PubMed ID: 34742397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions.
    Coplan L; Zhang Z; Ragone N; Reeves J; Rodriguez A; Shevade A; Bak H; Tustian AD
    Biotechnol Prog; 2024; 40(3):e3445. PubMed ID: 38450973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities.
    Moço PD; Xu X; Silva CAT; Kamen AA
    Biotechnol J; 2023 Sep; 18(9):e2300051. PubMed ID: 37337925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.
    Nambiar B; Cornell Sookdeo C; Berthelette P; Jackson R; Piraino S; Burnham B; Nass S; Souza D; O'Riordan CR; Vincent KA; Cheng SH; Armentano D; Kyostio-Moore S
    Hum Gene Ther Methods; 2017 Feb; 28(1):23-38. PubMed ID: 28166648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
    Hildinger M; Baldi L; Stettler M; Wurm FM
    Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.
    Qiao C; Li J; Skold A; Zhang X; Xiao X
    J Virol; 2002 Feb; 76(4):1904-13. PubMed ID: 11799185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
    Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
    J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.